Back to Search Start Over

A comprehensive review of quantum bioreactor cell manufacture: Research and clinical applications.

Authors :
Hulme CH
Mennan C
McCarthy HS
Davies R
Lan T
Rix L
Perry J
Wright K
Source :
Cytotherapy [Cytotherapy] 2023 Oct; Vol. 25 (10), pp. 1017-1026. Date of Electronic Publication: 2023 May 09.
Publication Year :
2023

Abstract

The Quantum cell expansion system manufactured by Terumo-BCT is perhaps the most widely reported Good Manufacturing Practice-compliant bioreactor used for the expansion of adherent cell populations, both for research purposes and clinical cell-based therapies/trials. Although the system was originally designed for adherent cell expansion, more recently suspension cultures and extracellular vesicle manufacturing protocols have been published using the Quantum system. Cell therapy research and regenerative medicine in general is a rapidly expanding field and as such it is likely that the use of this system will become even more widespread and perhaps mandatory, for both research and development and in the clinic. The purpose of this review is to describe, compare and discuss the diverse range of research and clinical applications currently using the Quantum system, which to our knowledge has not previously been reviewed. In addition, current and future challenges will also be discussed.<br />Competing Interests: Declaration of Competing Interest The authors have no commercial, proprietary or financial interest in the products or companies described in this article.<br /> (Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1477-2566
Volume :
25
Issue :
10
Database :
MEDLINE
Journal :
Cytotherapy
Publication Type :
Academic Journal
Accession number :
37162433
Full Text :
https://doi.org/10.1016/j.jcyt.2023.04.004